Image Source:- >>  |  Content Source:- >>

Indian scientists have discovered an alternative drug molecule, Ruthenium Ferrocene Bimetallic, which has a dual action mechanism against cancer. It controls primary tumor growth antiproliferation and checks metastasis (growth) through antiangiogenesis.

The new agent restricts new blood vessel development and can help treat cancer cases that prove resistant to platinum drugs used for treating the disease.

Extensive biological investigations have been undertaken in cellular models and on zebrafish. The team is planning to experiment with the anti-cancer properties and toxicity of the new agent in mammals like mice.

About Ingenious e-Brain:-

Ingenious e-Brain provides high-quality, customized, and cost-effective Technology Research, Business Research, and Intellectual Property Research solutions to industry leaders and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide the highest quality results ensuring fool-proof confidentiality and security. We are an ISO-certified company with offices in India and USA.

Ingenious e-Brain has a strong team of analysts and subject matter experts with domain proficiency which is devoted to helping clients grow. Our highly qualified professionals offer tailored, value-added, and cost-effective services to our clients. We believe in building long-term relationships with our clients which include national and international corporations, Fortune 500 companies, the world’s leading research institutes and universities as well as independent inventors.

Get in Touch:-
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218

Email:-
contact@iebrain.com